BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21437770)

  • 21. Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy.
    Busk M; Horsman MR; Jakobsen S; Keiding S; van der Kogel AJ; Bussink J; Overgaard J
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1202-12. PubMed ID: 18313528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in tumor hypoxia measured with a double hypoxic marker technique.
    Ljungkvist AS; Bussink J; Rijken PF; Raleigh JA; Denekamp J; Van Der Kogel AJ
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1529-38. PubMed ID: 11121659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers.
    Goethals L; Debucquoy A; Perneel C; Geboes K; Ectors N; De Schutter H; Penninckx F; McBride WH; Begg AC; Haustermans KM
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):246-54. PubMed ID: 16618579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pimonidazole binding in C6 rat brain glioma: relation with lipid droplet detection.
    Zoula S; Rijken PF; Peters JP; Farion R; Van der Sanden BP; Van der Kogel AJ; Décorps M; Rémy C
    Br J Cancer; 2003 May; 88(9):1439-44. PubMed ID: 12778075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PET imaging of tumor hypoxia using 18F-labeled pimonidazole.
    Busk M; Jakobsen S; Horsman MR; Mortensen LS; Iversen AB; Overgaard J; Nordsmark M; Ji X; Lee DY; Raleigh JR
    Acta Oncol; 2013 Oct; 52(7):1300-7. PubMed ID: 23962243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Irradiation-dependent effects on tumor perfusion and endogenous and exogenous hypoxia markers in an A549 xenograft model.
    Fokas E; Hänze J; Kamlah F; Eul BG; Lang N; Keil B; Heverhagen JT; Engenhart-Cabillic R; An H; Rose F
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1500-8. PubMed ID: 20637978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pO₂ fluctuation pattern and cycling hypoxia in human cervical carcinoma and melanoma xenografts.
    Ellingsen C; Ovrebø KM; Galappathi K; Mathiesen B; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1317-23. PubMed ID: 22270159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local hypoxia is produced at sites of intratumour injection.
    Olive PL; Luo CM; Banáth JP
    Br J Cancer; 2002 Feb; 86(3):429-35. PubMed ID: 11875711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of EGFR under tumor hypoxia: identification of a subpopulation of tumor cells responsible for aggressiveness and treatment resistance.
    Hoogsteen IJ; Marres HA; van den Hoogen FJ; Rijken PF; Lok J; Bussink J; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):807-14. PubMed ID: 22420963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of antibody concentration in the assessment of cellular hypoxia by flow cytometry: EF5 and pimonidazole.
    Koch CJ
    Radiat Res; 2008 Jun; 169(6):677-88. PubMed ID: 18494550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in tumor hypoxia induced by mild temperature hyperthermia as assessed by dual-tracer immunohistochemistry.
    Sun X; Li XF; Russell J; Xing L; Urano M; Li GC; Humm JL; Ling CC
    Radiother Oncol; 2008 Aug; 88(2):269-76. PubMed ID: 18538874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.
    Kaanders JH; Wijffels KI; Marres HA; Ljungkvist AS; Pop LA; van den Hoogen FJ; de Wilde PC; Bussink J; Raleigh JA; van der Kogel AJ
    Cancer Res; 2002 Dec; 62(23):7066-74. PubMed ID: 12460928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors.
    Hoeben BA; Kaanders JH; Franssen GM; Troost EG; Rijken PF; Oosterwijk E; van Dongen GA; Oyen WJ; Boerman OC; Bussink J
    J Nucl Med; 2010 Jul; 51(7):1076-83. PubMed ID: 20554724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma.
    Varia MA; Calkins-Adams DP; Rinker LH; Kennedy AS; Novotny DB; Fowler WC; Raleigh JA
    Gynecol Oncol; 1998 Nov; 71(2):270-7. PubMed ID: 9826471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia and differentiation in squamous cell carcinomas of the uterine cervix: pimonidazole and involucrin.
    Azuma Y; Chou SC; Lininger RA; Murphy BJ; Varia MA; Raleigh JA
    Clin Cancer Res; 2003 Oct; 9(13):4944-52. PubMed ID: 14581369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
    Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
    Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy.
    Li XF; Carlin S; Urano M; Russell J; Ling CC; O'Donoghue JA
    Cancer Res; 2007 Aug; 67(16):7646-53. PubMed ID: 17699769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia.
    Hoogsteen IJ; Lok J; Marres HA; Takes RP; Rijken PF; van der Kogel AJ; Kaanders JH
    Eur J Cancer; 2009 Nov; 45(16):2906-14. PubMed ID: 19699082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: implications for radioresistance.
    Carnell DM; Smith RE; Daley FM; Saunders MI; Bentzen SM; Hoskin PJ
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):91-9. PubMed ID: 16563659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of microvessels in well-differentiated regions of human head and neck squamous cell carcinoma A253 associated with functional magnetic resonance imaging detectable hypoxia, limited drug delivery, and resistance to irinotecan therapy.
    Bhattacharya A; Tóth K; Mazurchuk R; Spernyak JA; Slocum HK; Pendyala L; Azrak R; Cao S; Durrani FA; Rustum YM
    Clin Cancer Res; 2004 Dec; 10(23):8005-17. PubMed ID: 15585636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.